Hepatitis A Vaccinations On The Rise In Asia With Travelers From Developed Nations Most At Risk
This article was originally published in PharmAsia News
Executive Summary
Hepatitis A is considered a high risk in Asia, but the infection is not known as a public health priority since most people develop immunity against HAV during early childhood when infections are usually asymptomatic.
You may also be interested in...
Vaccines Shakeup Continues In China: NT Pharma Backs Away From GSK
SHANGHAI - China's largest vaccine distributor China NT Pharma Group announced Aug. 17 it will not renew its master distribution contract with its largest customer GlaxoSmithKline PLC, in part, it appears, due to burdens created by the new China Pharmacopeia that was issued at the end of 2010
Shiseido Unveils Strategy For Returning Company To Growth In 2013
Shiseido has strategic initiatives planned for its domestic and Chinese businesses and Bare Escentuals in the U.S. following a disappointing fiscal 2012 in which the Toyko-based firm recorded a net loss of $148 million.
Newhall Laboratories Works To Refresh Venerable Personal-Care Brands
La Bella, L.A. Looks and Soft & Dri have new websites and new marketing strategies behind them as Newhall Laboratories endeavors to rejuvenate personal-care brands it’s acquired over the past year and a half.